Of Health and Human Services 21 Cfr

نویسنده

  • Victor P Frattali
چکیده

SUMMARY: The Food and Drug Administration (FDA) is adopting general requirements pertaining to: (1) The use of health claims that characterize the relationship of a substance to a disease or health related condition on the labels and in labeling of foods in conventional food form (conventional foods), and (2) the content of petitions regarding the use of such health, claims pertaining to specific substances in such food. This action is being taken in response to provisions of the Nutrition Labeling and Education Act of 1990 (the 1990 amendments) that bear on health claims for conventional foods. However, in the Dietary Supplement Act of 1992 (the DS Act), Congress imposed a moratorium on the implementation of the 1990 amendments with respect to dietary supplements with only very limited exceptions. Therefore, these final rules do not apply to dietary supplements of vitamins, minerals, herbs, or other similar nutritional substances. Elsewhere in this issue of the Federal Register, FDA is issuing final rules that respond, at least, with respect to conventional foods and, to the extent that they would permit claims, with respect, to dietary supplements, to the 1990 amendments' directive that the agency consider 10 topics associating substances with diseases or health-related conditions. Those final rules have been developed in accordance with the general principles of the requirements in this document. concerning restaurant firms consisting of 10 or less individual restaurant establishments for whom these sections will become effective on May 8, 1994. a proposed rule to establish, general requirements pertaining to: (1) The use of health claims that characterize the relationship of a substance to a disease or health-related condition on the labels and in labeling of both conventional foods and dietary supplements, and (2) the content of petitions regarding the use of such health claims pertaining to specific substances in food. The proposed rule was issued in response to provisions of the 1990 amendments (Pub. L. 101-535) that bear on health claims. With respect to health claims, the 1990 amendments amend the Federal Food, Drug, and Cosmetic Act (the act) by adding a provision (section 403(r)(1)(B) of the act (21 U.S.C. 343(r)(1)(B))) that provides that a product is misbranded if it bears a claim that characterizes the relationship of a nutrient to a disease or health-related condition, unless the claim is made in accordance with section 403(r)(3) or (r)(5)(D). Congress enacted the health claims provisions of the 1990 amendments to …

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 172 [Docket No. 91F-0228] Food Additives Permitted For Direct Addition to Food For Human Consumption; Sucrose Acetate Isobutyrate

The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of sucrose acetate isobutyrate (SAIB) as a stabilizer of emulsions of flavoring oils used in nonalcoholic beverages. This action is in response to a petition filed by Eastman Chemical Co. DATES: Effective (inserl date of publication in the Federal Register); written objections and reques...

متن کامل

Informed consent, confidentiality, and subject rights in clinical trials.

The informed consent process is designed to inform the subject of the risks, rights, and benefits of participation in a clinical research trial. Informed consent, while not always necessary, is a critical component of ethical research involving human subjects. This article includes an overview of two sets of regulations regarding informed consent found in the Code of Federal Regulations (CFR) T...

متن کامل

Out-of-hospital intubation of children.

5. O’Harrow R. Under fire, U.S. amends plan to collect health care data. Washington Post. April 1, 1999:A5. 6. Lo B, Alpers A. Uses and abuses of prescription drug information in pharmacy benefits management programs. JAMA. 2000;283:801-806. 7. Rosoff AJ. The changing face of pharmacy benefits management. St Louis University Law Journal. 1998;42:1-53. 8. California HealthCare Foundation. Medica...

متن کامل

OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR

The Food and Drug Administration (FDA or the Agency) is issuing a final order to require the filing of premarket approval applications (PMA) for automated external defibrillator (AED) systems, which consist of an AED and those AED accessories necessary for the AED to detect and interpret an electrocardiogram and deliver an electrical shock (e.g., pad electrodes, batteries, adapters, and hardwar...

متن کامل

Vitamin D2 versus D3 – Scientific Evidences

Vitamins D3 and D2 are chemically different. In contrast to vitamin D3, vitamin D2 has a double bond between carbons 22 and 23 and a methyl group on carbon 24 in its side chain. Irrespective of their chemical differences, the human body uses the same enzymatic pathways to transform these vitamins to their pro-hormone (conditional vitamins) and hormone forms. There are ongoing debates in the lit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2004